Engineering a living human Mini-heart and a swimming Bio-robot
The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.
Projectdetails
Introduction
Cardiovascular disease (CVD) is still the number one cause of death worldwide despite the significant efforts of academia and the pharmaceutical industry to understand the different underlying causes of CVD.
Challenges in Current Models
These efforts have been hampered by the lack of proper human cardiac models.
- Animal Models: Animal models have different physiology and gene expression from the human situation.
- In Vitro Models: Flat cell culture in vitro models are not capable of producing pumping motion, which is the main function of the heart.
Regulatory Concerns
Furthermore, pesticide toxicity and risk for human health are controlled at a European level through a well-developed regulatory network. However, cardiotoxicity is not described as a separate hazard class, even though it can have long-term cardiovascular complications.
Proposed Solution
Here we propose to create better predictive in vitro cardiac models by developing:
- A vascularized beating mini-heart
- A self-propulsion swimming bio-robot
These will be made by assembling human cardiac cells into 3D tissue structures using sacrificial molding and high-resolution 3D bio-printing.
Benefits of the Project
The mini-heart and the bio-robot will enable the scientific community to have:
- A more realistic human cardiac model in vitro
- A proper tool to assess the presence of cardiotoxicants in the environment
Consortium Collaboration
This work will be done in a consortium of four parties with the necessary expertise, including:
- Heart development
- Human pluripotent stem cells
- 3D bioprinting
- Tissue engineering
- Biosensing
Together, we aim to bring these engineered living tissues to reality.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.475.946 |
Totale projectbegroting | € 4.475.946 |
Tijdlijn
Startdatum | 1-11-2022 |
Einddatum | 31-10-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- UNIVERSITEIT TWENTEpenvoerder
- NANOSCALE SYSTEMS, NANOSS GMBH
- RIVER BIOMEDICS B.V.
- UNIVERSIDAD DE MALAGA
- METATISSUE - BIOSOLUTIONS, LDA
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
High-throughput ultrasound-based volumetric 3D printing for tissue engineeringSONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research. | EIC Pathfinder | € 2.999.625 | 2025 | Details |
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgansTHOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants. | EIC Pathfinder | € 3.994.150 | 2023 | Details |
Blood as energy source to power smart cardiac devicesThe BLOOD2POWER project aims to develop energy-harvesting vascular grafts using triboelectric nanogenerators to monitor performance and prevent failure through wireless data transmission. | EIC Pathfinder | € 2.885.525 | 2023 | Details |
High-throughput ultrasound-based volumetric 3D printing for tissue engineering
SONOCRAFT aims to revolutionize myocardial cell construct bioprinting by combining rapid volumetric printing with ultrasonic manipulation to create functional cardiac models for drug testing and disease research.
building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology for the fabrication of Human tissues and ORgans
THOR aims to revolutionize tissue engineering by creating patient-specific, fully functional human tissues using bioinspired mini-robots, eliminating the need for organ transplants.
Blood as energy source to power smart cardiac devices
The BLOOD2POWER project aims to develop energy-harvesting vascular grafts using triboelectric nanogenerators to monitor performance and prevent failure through wireless data transmission.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Advanced human models of the heart to understand cardiovascular diseaseHeart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine. | ERC Advanced... | € 2.500.000 | 2023 | Details |
Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular DiseaseThe 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health. | ERC Starting... | € 1.496.395 | 2022 | Details |
Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTsG-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease. | ERC Starting... | € 1.497.351 | 2022 | Details |
Bringing 3D cardiac tissues to high throughput for drug discovery screensDeveloping a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability. | EIC Transition | € 1.457.500 | 2023 | Details |
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughputHEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments. | ERC Consolid... | € 2.969.219 | 2022 | Details |
Advanced human models of the heart to understand cardiovascular disease
Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.
Development of novel 3D vascularized cardiac models to investigate Coronary Microvascular Disease
The 3DVasCMD project aims to develop a 3D vascularized cardiac model using iPSC technology to study coronary microvascular disease and identify therapeutic targets for improved cardiovascular health.
Computationally and experimentallY BioEngineeRing the next generation of Growing HEARTs
G-CYBERHEART aims to develop innovative experimental and computational methods for creating adaptable bioengineered hearts to improve treatment for congenital heart disease.
Bringing 3D cardiac tissues to high throughput for drug discovery screens
Developing a high-throughput 3D cardiac model using microfluidic technology to enhance drug discovery for cardiovascular disease by improving predictive accuracy and scalability.
3D-assembly of interactive microgels to grow in vitro vascularized, structured, and beating human cardiac tissues in high-throughput
HEARTBEAT aims to create personalized, vascularized millimeter-scale heart tissues using innovative microgel assemblies to enhance stem cell interactions and mimic native environments.